I2I market assessment for epileptic seizure prediction

癫痫发作预测的 I2I 市场评估

• 批准号: 478915-2015
• 负责人: Gras, Robin
• 金额: $ 0.88万
• 依托单位: University of Windsor
• 依托单位国家: 加拿大
• 项目类别: Idea to Innovation
• 财政年份: 2015
• 资助国家: 加拿大
• 起止时间: 2015-01-01 至 2016-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=579845
• 关键词: I2I; market; assessment; epileptic; seizure

A market study will be conducted to assess the viability of commercializing a novel method called GenericPred for epileptic seizure prediction. GenericPred is a mathematical algorithm for time series prediction and is applicable to a variety of fields including medicine, computer science, environmental science and economics. GenericPred has the advantage of being highly adaptable, consistent and computationally efficient. In one potential application, this novel method is used to predict the likely onset of epileptic seizures. Epilepsy afflicts 1 in 100 Canadians and nearly 1% of the global population. Electroencephalogram (EEG) readings record the electrical activity in the brain using flat discs called electrodes that are attached to a person's scalp. When the GenericPred method is applied to continuous EEG data, it can accurately predict when an epileptic seizure will occur. This novel method was evaluated by applying it to pre-recorded EEG data from 21 epileptic patients; the GenericPred method attained an accuracy level with 100% sensitivity and specificity for the prediction of epileptic seizures up to 17 minutes in advance. This method may have the potential to be incorporated as part of a health monitoring or warning system to provide an advance indication of other types of serious health events, such as heart attack and stroke. The ability to predict the onset of a seizure allows for epileptic patients to prepare accordingly to maximize their safety. Devices designed to warn patients of an approaching seizure allows patients to avoid potentially dangerous activities and works toward achieving an enhanced sense of normalcy in their lives. According to a Global Business Intelligence (GBI) Research report, the epilepsy therapeutics market value in eight major countries (United States, Canada, France, Germany, Italy, Spain, United Kingdom, Japan) is expected to grow from $3.4 billion in 2012 to $4.5 billion by 2019. This technology offers a potential innovative solution to assist those suffering from epilepsy to more effectively manage their seizures and to increase Canada's presence in the epileptic therapeutic market.

将进行一项市场研究，以评估一种名为GenericPred的癫痫发作预测新方法商业化的可行性。GenericPred是一种用于时间序列预测的数学算法，适用于包括医学、计算机科学、环境科学和经济学在内的各种领域。GenericPred具有高度适应性、一致性和计算效率的优势。在一个潜在的应用中，这种新的方法被用来预测癫痫发作的可能发生。每100名加拿大人中就有1人患有癫痫，占全球人口的近1%。脑电(EEG)读数使用连接在人头皮上的称为电极的扁平圆盘记录大脑中的电活动。当将GenericPred方法应用于连续的脑电数据时，它可以准确地预测癫痫发作的时间。通过对21例癫痫患者预先记录的脑电数据进行评估，该方法对癫痫发作的预测达到了100%的灵敏度和特异度，可提前17min。这种方法有可能作为健康监测或警告系统的一部分，为其他类型的严重健康事件提供预先指示，如心脏病发作和中风。 预测癫痫发作的能力使癫痫患者能够相应地做好准备，以最大限度地提高他们的安全性。旨在警告患者即将发作的设备使患者能够避免潜在的危险活动，并努力实现增强他们生活中的正常感。根据全球商业智能(GBI)研究报告，八个主要国家(美国、加拿大、法国、德国、意大利、西班牙、英国、日本)的癫痫治疗药物市场价值预计将从2012年的34亿美元增长到2019年的45亿美元。这项技术提供了一种潜在的创新解决方案，以帮助癫痫患者更有效地管理其癫痫发作，并增加加拿大在癫痫治疗市场的存在。